In the early morning of February 25, Beijing time, Bloomberg News reported on Thursday that PerkinElmer Inc. (PerkinElmer Inc.) missed the acquisition of medical instrument manufacturing at a 25-cent disadvantage in the bidding that ended this month. Opportunities for Beckman Coulter Inc.

The report also quoted people familiar with the matter as saying that PerkinElmer's offer of $83.25 per share has maintained its lead almost all the way. It wasn't until the last minute that Danaher Inc., a diversified industrial conglomerate, beat PerkinElmer by a margin of 25 cents.

The report pointed out that PerkinElmer originally hoped to enrich the company's lack of diagnostic equipment in genetic screening and environmental protection testing by acquiring Beckman Coulter. The failure of this bidding makes PerkinElmer have to consider looking for a larger acquisition target, or consider selling itself as a whole. Data show that Danaher's $6.8 billion acquisition offer for Beckman Coulter is almost equivalent to more than twice the market value of PerkinElmer.

According to the regulatory documents submitted by Beckman Coulter, the company's M&A consultant Goldman Sachs believes that Danaher's offer is "a better result for the company's shareholders as a whole" and believes that its acquisition offer is most likely to be realized. According to the report, PerkinElmer needs nearly US$7 billion in credit financing, while Danaher has promised about 25% of cash payments and plans to pay the balance through bond issuance and share enhancement.